ARPA-H Launches Two New Programs
EMBODY: Engineering of Immune Cells Inside the Body
The goal of EMBODY is to radically alter how immune therapies are developed and delivered for life-threatening and chronic conditions by retraining healthy immune cells, and eliminating time, cost and access hurdles.
“By developing agents that target specific immune cell types, essentially providing instructions to cells already active inside your body, we hope to make advanced immunotherapies available close to home for Americans across the country,” said EMBODY Program Manager Daria Fedyukina, Ph.D., in ARPA-H’s recent program announcement.
PRINT (Personalized Regenerative Immunocompetent Nanotechnology Tissue)
PRINT intends to use state-of-the-art bioprinting technology and a regenerative medicine approach to 3D print personalized, on organs that will not require immunosuppressive drugs.
“By starting from multiple different types of cells, we will be creating organs that will be individually matched,” said PRINT Program Manager Ryan Spitler, Ph.D., in ARPA-H’s recent program announcement. “The body will not recognize it as a foreign entity, eliminating the need of immunosuppressive drugs, which has never been done in the history of organ transplantation.”
To learn more about both programs, including how to register for the upcoming Proposers’ Days, visit the EMBODY program page and PRINT program page
- miR-21, miR-221, miR-29 and miR-34 are distinguishable molecular features of a … – PLOS
Affiliations: Laboratory of Immunology and Cellular and Molecular Biology, Faculty of Chemical Sciences, Autonomous University of San Luis Potosí … - Role of Granzyme K and Amphiregulin in IgG4-RD: Insights into CTLs and B Cells
… Immunology by Koga, et al. IgG4-related disease (IgG4-RD) represents a type I immune disease characterized by dysregulated resolution of … - Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO
Even as new Sanofi drugs like Beyfortus and Altuviiio come into their own, the French pharma's immunology powerhouse Dupixent shows no signs of … - Data in the real world – IMMUNE MATTERS
Could it rip through immune cell defenses to trigger severe cases of COVID-19? Researchers at La Jolla Institute for Immunology (LJI) worked quickly … - Immunologist receives biomedical research award – Cornell Chronicle
Ashley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell …